Who Owns Century Therapeutics Stock?
NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 88.02%
- Held by insiders
- 8.58%
- Institutional holders
- 134
- Institutions 88.0%
- Insiders 8.6%
- Public and other 3.4%
Who owns Century Therapeutics stock?
Institutional investors own about 88.0% of Century Therapeutics's shares, spread across 134 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 8.58% of IPSC.
The largest institutional holders are RA Capital Management, L.P. (9.80%), TCG Crossover Management, LLC (9.80%) and Versant Venture Management, LLC (6.72%). Together, the top 10 institutions control 56.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their IPSC positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IPSC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 17.75M | 9.80% | 0.0% |
| TCG Crossover Management, LLC | 17.75M | 9.80% | 0.0% |
| Versant Venture Management, LLC | 12.17M | 6.72% | 0.0% |
| Deep Track Capital, Lp | 9.46M | 5.23% | -0.3% |
| Commodore Capital Lp | 8.70M | 4.80% | 0.0% |
| RTW Investments LP | 8.70M | 4.80% | 0.0% |
| Venrock Adviser, LLC | 8.70M | 4.80% | 0.0% |
| Blackrock Inc. | 8.09M | 4.47% | +430.8% |
| Vanguard Capital Management LLC | 5.70M | 3.15% | +0.3% |
| Balyasny Asset Management LP | 5.52M | 3.05% | +10.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IPSC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.34M | 2.40% |
| iShares Trust-iShares Russell 2000 ETF | 3.04M | 1.68% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.34M | 0.74% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.22M | 0.68% |
| iShares Trust-iShares Russell 2000 Value ETF | 1.19M | 0.66% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 707.56K | 0.39% |
| Northern Funds-SMALL CAP VALUE FUND | 549.93K | 0.30% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 458.92K | 0.25% |
| iShares Trust-iShares Micro-Cap ETF | 388.76K | 0.21% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 299.45K | 0.17% |
Frequently asked questions
Who is the largest shareholder of Century Therapeutics?
RA Capital Management, L.P. is the largest institutional shareholder of IPSC, owning 9.80% of shares outstanding (17.75M shares) as of its latest 13F filing.
What percentage of Century Therapeutics is owned by institutions?
Institutions own about 88.0% of IPSC shares and 96.3% of the public float.
How much of Century Therapeutics do insiders own?
Insiders, such as officers and directors, own about 8.58% of IPSC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.